Lancet Market Size, Share, Trends & Forecast by 2033

Lancet Market Outlook from 2023 to 2033

The lancet market valuation is estimated to be US$ 1.4 billion in 2023. Manufacturers are increasingly transforming the healthcare landscape by innovating low-pain devices for blood glucose. This lays the groundwork for substantial growth, with estimates suggesting the market could surpass US$ 3.7 billion by 2033. This growth trajectory is underpinned by an exceptional CAGR of 10.5%, highlighting the market's remarkable potential over the next decade.

Key Highlights

The demand for the lancet market is exemplified by factors such as the increase in diabetes patients and the growing use of lancets in non-invasive blood glucose monitoring.
The lancet market has recently gained significant attention due to increasing global technical advancements.
Due to the rising aging population worldwide, the market is gaining immense and lucrative growth in regions such as North America and Asia Pacific.
The top manufacturers continuously evolve their portfolios with innovative technologies and upgrades for painless experiences.

Attributes	Details
Lancet Market Size in 2022	US$ 1.2 billion
Lancet Market Size in 2023	US$ 1.4 billion
Projected Market Size by 2033	US$ 3.7 billion
Value-based CAGR from 2023 to 2033	10.5%

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Top Trends Shaping the Global Lancet Market

Rising in Diabetes Patients Worldwide

Lancets are in demand as chronic diseases like diabetes and cardiovascular ailments become more common. This is because lancets are necessary for routine blood testing and monitoring. Furthermore, the development of medical technology has led to the creation of more inventive and user-friendly self-monitoring devices, improving patient comfort.
According to an article published in 2023 about diabetes states that by 2050, more than 1 billion people will be living with diabetes. Moreover, of all the diabetes prevalence, Type 2 accounted for 90% in the previous year. The amount spent on healthcare worldwide is also increasing, and both public and private organizations have made considerable investments in healthcare infrastructure to minimize the burden of expenditure from low and middle-income countries. Furthermore, the focus of the World Health Assembly on biomedical interventions and new devices may drive the market for diabetes-related devices and drugs.
Lancet utilization has increased due to the growing tendency toward preventative healthcare and tailored therapy. For instance, in 2020, European countries spent around 3.7% of expenditure on preventive care.

Growing Use of Lancets in Non-invasive Blood Glucose Monitoring

Non-invasive blood glucose monitoring devices are becoming increasingly popular as they offer several advantages over traditional blood glucose meters. Non-invasive devices are easier to use and less time-consuming, as they do not require a needle prick and are also less likely to cause pain and bleeding.
For instance, Senseonic launched a subcutaneous implant device, Eversense, for diabetes patients, which was approved by the FDA in 2019. The device can measure glucose levels and with the help of a small sensor implanted in the skin, it sends the data at every 5 minutes to the connected smartphone.

Integration of Lancets with Other Blood Sampling and Testing Devices

Lancets are increasingly being integrated with other blood sampling and testing devices, such as blood glucose meters and cholesterol monitors. This integration makes it easier and more convenient for patients to collect and test their blood samples.
A recent study published in the journal Clinical Chemistry found that integrated blood sampling and testing devices were more accurate and easier to use than traditional lancets. The study also found that integrated devices can help to reduce the risk of contamination.
The integration of lancets with other blood sampling and testing devices is expected to drive growth in the lancet market in the coming years. As more patients adopt integrated devices, the demand for lancets is expected to increase.

Historical Analysis of the Lancet Market

The lancet market is projected to grow at a rate far eclipsing the pace during the historical period from 2018 to 2022. Rising technology advancements in devices that provide accurate and compact designs contribute to the immense growth in the market.

Historical Market Valuation, 2022	US$ 1.2 billion

The demand for healthcare technology management has risen during the pandemic. COVID-19 boosted the pharmaceutical sector as it has indirectly increased cases of cardiac arrest, diabetes, and other illnesses.

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Country-wise Insights

From 2023 to 2033, Japan regained the global lancet market, claiming an impressive 11.9% share. This signifies a significant foothold in the industry. Meanwhile, China is just a little behind, holding a substantial 11% share. This solidifies Asia’s notable presence in the market, making the Asia Pacific significant contributions to the lancet market’s growth and development.

Countries	CAGR (2023 to 2033)
United States	10.7%
United Kingdom	9.6%
China	11.0%
Japan	11.9%
South Korea	8.1%

Increase in the Aging Population in the United States

The aging population drives the demand for lancets, the high prevalence of chronic diseases, and the increasing use of lancets in non-invasive blood glucose monitoring is driving the market in the country.

According to the National Institute of Health, nearly 40% of the aging population in the United States has diabetes, and around 33% of older adults are at risk of kidney failure and heart disease. There is a growing trend toward the use of new lancet technologies, such as micro-needles and lancets, that are integrated with other blood sampling and testing devices.

The Rising Prevalence of Chronic Diseases in the United Kingdom

The well-equipped infrastructure and medical technology are expected to drive the market in the forecast period in a country. Increasing R&D research activities to create innovative products and technologies is also expected to create lucrative regional opportunities.

The aging population drives the demand for lancets, the high prevalence of chronic diseases, and the increasing use of lancets in non-invasive blood glucose monitoring.

China Leading Growth of the Market in the Asia Pacific

China is anticipated to register a CAGR of 11.0% in the global market by 2033. The rising medical and healthcare awareness are advancements in lanced devices driving the market in China. These initiatives bring strong emphasis to the healthcare sector.

Market growth is increasing owing to factors such as rapid urbanization, the introduction of SMBG (self-monitoring of blood glucose), and the rising population, which is expected to uplift the market in the country.

The demand for lancets is driven by the increasing prevalence of chronic diseases, such as diabetes, and the rising demand for point-of-care testing. The Chinese government is supportive of the lancet industry and has provided funding for research and development.

Increasing Government Initiatives for Aging Population in Japan Driving Market Growth

The lancet market in Japan is expected to retain its sizeable market share in the assessment period. As per the recent market estimates, the country is expected to acquire an 11.9% market share through 2023. The prominent stance of the Japan market in the global scape can be attributed to early access to advanced technology.

The aging population drives the demand for lancets in Japan, the high prevalence of chronic diseases, and the growing popularity of remote patient monitoring. The Japanese government actively participates in funding for research and development for insulin therapy and techniques to improve blood glucose monitoring.

Category-wise Insights

Medication Dispensing System Dominate the Market by Top Product

Top Product	Safety Lancet
CAGR (2023 to 2033)	10.2%

The safety lancet segment is expected to thrive at a 10.2% CAGR over the forecast period. The Safety lancet is dominating the market owing to its increasing use by healthcare professionals worldwide. The safety lancet has advantages such as prevention from sharp injuries, needle stick injuries, and other accidents.

Inpatient Pharmacies to Dominate the Market

Top End Use	Hospitals & Clinics
CAGR (2023 to 2033)	10.0%

Hospitals and clinics are expected to grow at a rate of 10.0% over the forecast period. The Hospital & clinics segment dominated the market in the forecast period due to the increasing need for lancets to treat chronic diseases.

Competitive Landscape in the Lancet Market

Ongoing enhancements in needle design for bevel length are unveiling a new set of treatment options. Moreover, improving the performance and accuracy of BG devices is expected to bring about many changes and present opportunities for manufacturers.

The lancet market is fragmented, with several key players eying to advance safety lancet. Pharmaceutical manufacturers also receive increasing approvals and regulatory clearance to enhance their portfolios.

Recent Developments

In June 2023, the World Health Organization (WHO) released a new report on the use of lancets in developing countries. The report found that lancets are a valuable tool for improving access to blood testing and monitoring in developing countries.
In May 2023, Abbott Laboratories announced that it is developing a new non-invasive blood glucose monitoring device called the FreeStyle LibreLink. This device will use a sensor on the arm to track glucose levels 24/7. The device will also be calibrated using a lancet.
In July 2023, Terumo Corporation announced the launch of its new Microsite lancet. This lancet is made from biodegradable materials, making it more environmentally friendly than traditional lancets.

Key Companies Profiled in the Lancet Market

Becton, Dickinson, and Company (BD)
F. Hoffmann-La Roche Ltd
B. Braun Melsungen AG
Abbott Laboratories
Terumo Corporation
Medline Industries, Inc.
Nipro Medical Corporation
Saf-T-Blood, Inc.
Sarstedt AG & Co.
Owen Mumford Ltd.
Bayer AG

Key Segments in the Lancet Market

By Type:

Safety Lancet
Push Button Safety Lancet
Pressure Activated Safety Lancet
Side Button Safety Lancet
Personal Lancet

By End Use:

Hospitals & Clinics
Diagnostic Centers and Pathology Laboratories
Home Diagnostics
Research and Academic Laboratories

By Region:

North America
Latin America
Western Europe
Eastern Europe
Asia Pacific Excluding Japan (APEJ)
Japan
The Middle East & Africa

Frequently Asked Questions

How Big is the Lancet Market?

The global Lancet Market will be worth US$ 1.4 billion in 2023.

What is the Growth Potential of the Lancet Market in the United States?

The United States is likely to record a growth of 10.7% from 2023 to 2033.

What will be the Lancet's Market Value by 2033?

The market size is projected to surpass US$ 3.7 billion by 2033.

Why is the Demand for Safety Lancets High?

The safety lancets experience high demand owing to rising usage in hospitals and clinics.

Which Country is Leading the Lancet Market?

Japan is driving the demand for lancet, with a growth rate of 11.9% through 2033.

Table of Content

1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Supply Chain Analysis
3.5.1. Supply Side Participants and their Roles
3.5.1.1. Producers
3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)
3.5.1.3. Wholesalers and Distributors
3.5.2. Value Added and Value Created at Node in the Supply Chain
3.5.3. List of Raw Material Suppliers
3.5.4. List of Existing and Potential Buyer’s
3.6. Investment Feasibility Matrix
3.7. Value Chain Analysis
3.7.1. Profit Margin Analysis
3.7.2. Wholesalers and Distributors
3.7.3. Retailers
3.8. PESTLE and Porter’s Analysis
3.9. Regulatory Landscape
3.9.1. By Key Regions
3.9.2. By Key Countries
3.10. Regional Parent Market Outlook
3.11. Production and Consumption Statistics
3.12. Import and Export Statistics
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Type, 2018 to 2022
5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Type, 2023 to 2033
5.3.1. Safety Lancet
5.3.2. Push Button Safety Lancet
5.3.3. Pressure Activated Safety Lancet
5.3.4. Side Button Safety Lancet
5.3.5. Personal Lancet
5.4. Y-o-Y Growth Trend Analysis By Type, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Type, 2023 to 2033
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By End User, 2018 to 2022
6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By End User, 2023 to 2033
6.3.1. Hospitals & Clinics
6.3.2. Diagnostic Centers and Pathology Laboratories
6.3.3. Home Diagnostics
6.3.4. Research and Academic Laboratories
6.4. Y-o-Y Growth Trend Analysis By End User, 2018 to 2022
6.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033
7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
7.1. Introduction
7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2018 to 2022
7.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2023 to 2033
7.3.1. North America
7.3.2. Latin America
7.3.3. Western Europe
7.3.4. Eastern Europe
7.3.5. South Asia and Pacific
7.3.6. East Asia
7.3.7. Middle East and Africa
7.4. Market Attractiveness Analysis By Region
8. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
8.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
8.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
8.2.1. By Country
8.2.1.1. USA
8.2.1.2. Canada
8.2.2. By Type
8.2.3. By End User
8.3. Market Attractiveness Analysis
8.3.1. By Country
8.3.2. By Type
8.3.3. By End User
8.4. Key Takeaways
9. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
9.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
9.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
9.2.1. By Country
9.2.1.1. Brazil
9.2.1.2. Mexico
9.2.1.3. Rest of Latin America
9.2.2. By Type
9.2.3. By End User
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Type
9.3.3. By End User
9.4. Key Takeaways
10. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. Germany
10.2.1.2. UK
10.2.1.3. France
10.2.1.4. Spain
10.2.1.5. Italy
10.2.1.6. Rest of Western Europe
10.2.2. By Type
10.2.3. By End User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Type
10.3.3. By End User
10.4. Key Takeaways
11. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. Poland
11.2.1.2. Russia
11.2.1.3. Czech Republic
11.2.1.4. Romania
11.2.1.5. Rest of Eastern Europe
11.2.2. By Type
11.2.3. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Type
11.3.3. By End User
11.4. Key Takeaways
12. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. India
12.2.1.2. Bangladesh
12.2.1.3. Australia
12.2.1.4. New Zealand
12.2.1.5. Rest of South Asia and Pacific
12.2.2. By Type
12.2.3. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Type
12.3.3. By End User
12.4. Key Takeaways
13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. China
13.2.1.2. Japan
13.2.1.3. South Korea
13.2.2. By Type
13.2.3. By End User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Type
13.3.3. By End User
13.4. Key Takeaways
14. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
14.2.1. By Country
14.2.1.1. GCC Countries
14.2.1.2. South Africa
14.2.1.3. Israel
14.2.1.4. Rest of MEA
14.2.2. By Type
14.2.3. By End User
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Type
14.3.3. By End User
14.4. Key Takeaways
15. Key Countries Market Analysis
15.1. USA
15.1.1. Pricing Analysis
15.1.2. Market Share Analysis, 2022
15.1.2.1. By Type
15.1.2.2. By End User
15.2. Canada
15.2.1. Pricing Analysis
15.2.2. Market Share Analysis, 2022
15.2.2.1. By Type
15.2.2.2. By End User
15.3. Brazil
15.3.1. Pricing Analysis
15.3.2. Market Share Analysis, 2022
15.3.2.1. By Type
15.3.2.2. By End User
15.4. Mexico
15.4.1. Pricing Analysis
15.4.2. Market Share Analysis, 2022
15.4.2.1. By Type
15.4.2.2. By End User
15.5. Germany
15.5.1. Pricing Analysis
15.5.2. Market Share Analysis, 2022
15.5.2.1. By Type
15.5.2.2. By End User
15.6. UK
15.6.1. Pricing Analysis
15.6.2. Market Share Analysis, 2022
15.6.2.1. By Type
15.6.2.2. By End User
15.7. France
15.7.1. Pricing Analysis
15.7.2. Market Share Analysis, 2022
15.7.2.1. By Type
15.7.2.2. By End User
15.8. Spain
15.8.1. Pricing Analysis
15.8.2. Market Share Analysis, 2022
15.8.2.1. By Type
15.8.2.2. By End User
15.9. Italy
15.9.1. Pricing Analysis
15.9.2. Market Share Analysis, 2022
15.9.2.1. By Type
15.9.2.2. By End User
15.10. Poland
15.10.1. Pricing Analysis
15.10.2. Market Share Analysis, 2022
15.10.2.1. By Type
15.10.2.2. By End User
15.11. Russia
15.11.1. Pricing Analysis
15.11.2. Market Share Analysis, 2022
15.11.2.1. By Type
15.11.2.2. By End User
15.12. Czech Republic
15.12.1. Pricing Analysis
15.12.2. Market Share Analysis, 2022
15.12.2.1. By Type
15.12.2.2. By End User
15.13. Romania
15.13.1. Pricing Analysis
15.13.2. Market Share Analysis, 2022
15.13.2.1. By Type
15.13.2.2. By End User
15.14. India
15.14.1. Pricing Analysis
15.14.2. Market Share Analysis, 2022
15.14.2.1. By Type
15.14.2.2. By End User
15.15. Bangladesh
15.15.1. Pricing Analysis
15.15.2. Market Share Analysis, 2022
15.15.2.1. By Type
15.15.2.2. By End User
15.16. Australia
15.16.1. Pricing Analysis
15.16.2. Market Share Analysis, 2022
15.16.2.1. By Type
15.16.2.2. By End User
15.17. New Zealand
15.17.1. Pricing Analysis
15.17.2. Market Share Analysis, 2022
15.17.2.1. By Type
15.17.2.2. By End User
15.18. China
15.18.1. Pricing Analysis
15.18.2. Market Share Analysis, 2022
15.18.2.1. By Type
15.18.2.2. By End User
15.19. Japan
15.19.1. Pricing Analysis
15.19.2. Market Share Analysis, 2022
15.19.2.1. By Type
15.19.2.2. By End User
15.20. South Korea
15.20.1. Pricing Analysis
15.20.2. Market Share Analysis, 2022
15.20.2.1. By Type
15.20.2.2. By End User
15.21. GCC Countries
15.21.1. Pricing Analysis
15.21.2. Market Share Analysis, 2022
15.21.2.1. By Type
15.21.2.2. By End User
15.22. South Africa
15.22.1. Pricing Analysis
15.22.2. Market Share Analysis, 2022
15.22.2.1. By Type
15.22.2.2. By End User
15.23. Israel
15.23.1. Pricing Analysis
15.23.2. Market Share Analysis, 2022
15.23.2.1. By Type
15.23.2.2. By End User
16. Market Structure Analysis
16.1. Competition Dashboard
16.2. Competition Benchmarking
16.3. Market Share Analysis of Top Players
16.3.1. By Regional
16.3.2. By Type
16.3.3. By End User
17. Competition Analysis
17.1. Competition Deep Dive
17.1.1. HTL-STREFA S.A. (Poland)
17.1.1.1. Overview
17.1.1.2. Product Portfolio
17.1.1.3. Profitability by Market Segments
17.1.1.4. Sales Footprint
17.1.1.5. Strategy Overview
17.1.1.5.1. Marketing Strategy
17.1.1.5.2. Product Strategy
17.1.1.5.3. Channel Strategy
17.1.2. Terumo Corporation (Japan)
17.1.2.1. Overview
17.1.2.2. Product Portfolio
17.1.2.3. Profitability by Market Segments
17.1.2.4. Sales Footprint
17.1.2.5. Strategy Overview
17.1.2.5.1. Marketing Strategy
17.1.2.5.2. Product Strategy
17.1.2.5.3. Channel Strategy
17.1.3. Becton Dickinson and Company (US)
17.1.3.1. Overview
17.1.3.2. Product Portfolio
17.1.3.3. Profitability by Market Segments
17.1.3.4. Sales Footprint
17.1.3.5. Strategy Overview
17.1.3.5.1. Marketing Strategy
17.1.3.5.2. Product Strategy
17.1.3.5.3. Channel Strategy
17.1.4. Hoffmann-La Roche Ltd. (Switzerland)
17.1.4.1. Overview
17.1.4.2. Product Portfolio
17.1.4.3. Profitability by Market Segments
17.1.4.4. Sales Footprint
17.1.4.5. Strategy Overview
17.1.4.5.1. Marketing Strategy
17.1.4.5.2. Product Strategy
17.1.4.5.3. Channel Strategy
17.1.5. Improve Medical Instruments Co. Ltd. (US)
17.1.5.1. Overview
17.1.5.2. Product Portfolio
17.1.5.3. Profitability by Market Segments
17.1.5.4. Sales Footprint
17.1.5.5. Strategy Overview
17.1.5.5.1. Marketing Strategy
17.1.5.5.2. Product Strategy
17.1.5.5.3. Channel Strategy
17.1.6. Bayer AG (Germany)
17.1.6.1. Overview
17.1.6.2. Product Portfolio
17.1.6.3. Profitability by Market Segments
17.1.6.4. Sales Footprint
17.1.6.5. Strategy Overview
17.1.6.5.1. Marketing Strategy
17.1.6.5.2. Product Strategy
17.1.6.5.3. Channel Strategy
17.1.7. Sarstedt AG & Co. (Germany)
17.1.7.1. Overview
17.1.7.2. Product Portfolio
17.1.7.3. Profitability by Market Segments
17.1.7.4. Sales Footprint
17.1.7.5. Strategy Overview
17.1.7.5.1. Marketing Strategy
17.1.7.5.2. Product Strategy
17.1.7.5.3. Channel Strategy
17.1.8. Abbott Laboratories (US)
17.1.8.1. Overview
17.1.8.2. Product Portfolio
17.1.8.3. Profitability by Market Segments
17.1.8.4. Sales Footprint
17.1.8.5. Strategy Overview
17.1.8.5.1. Marketing Strategy
17.1.8.5.2. Product Strategy
17.1.8.5.3. Channel Strategy
17.1.9. Greiner Bio-One International GmbH (US)
17.1.9.1. Overview
17.1.9.2. Product Portfolio
17.1.9.3. Profitability by Market Segments
17.1.9.4. Sales Footprint
17.1.9.5. Strategy Overview
17.1.9.5.1. Marketing Strategy
17.1.9.5.2. Product Strategy
17.1.9.5.3. Channel Strategy
18. Assumptions & Acronyms Used
19. Research Methodology

Lancet Market

Lancet Market Forecast by Side and Push Button Safety Lancet Type from 2023 to 2033